Related Experiment Video
Updated: Aug 6, 2026
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Structural basis for the functions of endogenous angiogenesis inhibitors
1Center for Matrix Biology and Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
Tipping the angiogenic balance between pro- and antiangiogenic stimuli to favor vasculature induction and enhanced angiogenesis is a key event in the growth and progression of tumors. Recently, we demonstrated that the genetic loss of normal physiological levels of individual endogenous inhibitors of angiogenesis leads to a change in the balance between proangiogenic stimulators and their inhibitors, thus favoring enhanced angiogensis and increased tumor growth. Therefore, these endogenous angiogenesis inhibitors provide a physiological threshold against the induction of angiogenesis. The antiangiogenic activities of endostatin, tumstatin, and thrombospondin-1 are evaluated and correlated with their three-dimensional structure and active sites, deriving a structural basis for their activities. Collectively, structural analysis of all three inhibitors demonstrates that the active antiangiogenic sites on these molecules are exposed on the surface and available to bind their putative integrin receptors on proliferating endothelial cells.
Insights
Loss of natural angiogenesis inhibitors shifts the balance, promoting tumor growth. Structural analysis reveals these inhibitors
Area of Science:
- Oncology
- Molecular Biology
- Structural Biology
Background:
- Tumor growth and progression depend on shifting the angiogenic balance towards vasculature induction.
- Loss of endogenous angiogenesis inhibitors disrupts this balance, favoring tumor vascularization and growth.
- Endogenous angiogenesis inhibitors establish a physiological threshold against excessive blood vessel formation.
Purpose of the Study:
- To evaluate the antiangiogenic activities of endostatin, tumstatin, and thrombospondin-1.
- To correlate their antiangiogenic activities with their three-dimensional structures and active sites.
- To establish a structural basis for the antiangiogenic functions of these key inhibitors.
Main Methods:
- Evaluation of the antiangiogenic activities of selected endogenous inhibitors.
- Three-dimensional structural analysis of endostatin, tumstatin, and thrombospondin-1.
- Correlation of molecular structure with observed antiangiogenic function.
Main Results:
- Structural analysis revealed exposed, surface-accessible active sites on all three inhibitors.
- These active sites are available for binding to putative integrin receptors on endothelial cells.
- The structural accessibility of active sites provides a basis for their potent antiangiogenic effects.
Conclusions:
- Endogenous angiogenesis inhibitors like endostatin, tumstatin, and thrombospondin-1 possess critical antiangiogenic functions.
- Their antiangiogenic activity is intrinsically linked to their molecular structure and the accessibility of their active sites.
- Understanding these structural-functional relationships is key to targeting angiogenesis in cancer therapy.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:10Mechanism of Angiogenesis
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:24Overview of Cell-Matrix Interactions